IMS 4112 and VLP of HBV as Th1 Adjuvants for a Recombinant Protein of HIV-1

Ingrid Rodríguez Alonso,Daymir García,Emma Brown,Stéphane Ascarateil,Enrique Iglesias

IMS 4112 and VLP of HBV as Th1 Adjuvants for a Recombinant Protein of HIV-1

2016

Ingrid Rodríguez Alonso
Daymir García
Emma Brown
Stéphane Ascarateil
Enrique Iglesias

Background: Current thinking suggests that vaccination approaches against the HIV-1 should be directed to elicit a Th1 cell-mediated immunity, neutralizing antibodies and/or ADCC mediating antibody responses.

Keywords:

Virology
Antibody
Immunity
Antibody-dependent cell-mediated cytotoxicity
Vaccination
Recombinant DNA
Biology
human immunodeficiency virus
antibody response
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations